Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy
Clinical trial NCT01297101 · TEMPORARILY_NOT_AVAILABLE
Trial details
- NCT number
- NCT01297101
- Sponsor
- Shanghai Chest Hospital
- Status
- TEMPORARILY_NOT_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.